BioLine RX Ltd.


Stock Update (NASDAQ:BLRX): Here’s Why Bioline RX Ltd Shares Jumped 17%

Bioline RX Ltd (NASDAQ:BLRX) investors are cheering the news that the company has signed an exclusive, worldwide agreement with BGN Technologies, the Technology Transfer …

Company Update (NASDAQ:BLRX): BioLineRx Ltd. Presents Corporate Objectives at Investor Breakfast Meeting in NY

Bioline RX Ltd (NASDAQ:BLRX) announced its corporate objectives at an ongoing investor breakfast meeting at theConvene Conference Center near Grand Central in New York …

Company Update (NASDAQ:BLRX): Bioline RX Ltd Announces Initiation of Phase 2a Trial of BL-8040 in Combination With KEYTRUDA® (pembrolizumab) for Treatment of Pancreatic Cancer

Bioline RX Ltd (NASDAQ:BLRX) announced the initiation of a Phase 2a trial investigating BL-8040 in combination with KEYTRUDA® (pembrolizumab), MSD’s anti-PD-1 therapy, in patients …

Company Update (NASDAQ:BLRX): Bioline RX Ltd Presents Final Results from Phase 2a Trial for Relapsed/Refractory AML at SOHO Conference

Bioline RX Ltd (NASDAQ:BLRX) announced that the successful final results of BL-8040’s Phase 2a clinical trial in relapsed or refractory acute myeloid leukemia (r/r …

Company Update (NASDAQ:BLRX): Bioline RX Ltd Announces Clinical Research Collaboration to Investigate Combination of BL-8040 with Atezolizumab in Multiple Oncology Indications

Bioline RX Ltd (NASDAQ:BLRX) announced that it has entered into a collaboration with Genentech, a member of the Roche Group, to support several Phase …

Company Update (NASDAQ:BLRX): Bioline RX Ltd and I-Bridge Capital Establish a New Drug Development Joint Venture in China

Bioline RX Ltd (NASDAQ:BLRX), a clinical stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that it has established …

Company Update (NASDAQ:BLRX): Bioline RX Ltd Signs Second Clinical Immuno-Oncology Collaboration

Bioline RX Ltd (NASDAQ:BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today the signing of a collaboration …

Company Update (NASDAQ:BLRX): Bioline RX Ltd Announces In-licensing of Liver Fibrosis Project Under Strategic Collaboration

Bioline RX Ltd (NASDAQ:BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that it has signed an …

Stock Update (NASDAQ:BLRX): Bioline RX Ltd Announces Regulatory Submissions for Phase 2a Trial of BL-8040 in Combination with KEYTRUDA for Treatment of Pancreatic Cancer

Bioline RX Ltd (NASDAQ:BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today the filing of regulatory submissions …

Stock Update (NASDAQ:BLRX): Bioline RX Ltd and MaRS Innovation Sign Framework Collaboration Agreement

Bioline RX Ltd (NASDAQ:BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that it has signed a …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts